Sutherland S K
Med J Aust. 1977 Apr 23;1(17):613-5.
Infusion of concentrated heterologous serum proteins may precipitate severe reactions in humans. Some of these reactions are not due to a preexisting hypersensitivity to the foreign protein, but rather to the strongly anticomplementary activity (ACA) of the infused protein. The latter mechanism could account for the occasional anaphylactoid reaction seen in a patient who has had no known previous exposure to the foreign protein. Similarly, it could account for the patient who fails to react to a preliminary subcutaneous trial dose, but then collapses when he is infused later with the same preparation. Nine commercial antivenoms from nine countries were examined and most were found to have high levels of anticomplementary activity. Considerable variation was found in both the immunochemical properties and the anticomplementary activity of these antivenoms. Antitoxins of equine origin to the toxins of diphtheria, tetanus and gas gangrene were also found to have high anticomplementary activity. Because of this activity these preparations should always be diluted and infused slowly. Lack of reaction to a test dose will never guarantee an uneventful infusion, and thus all infusions of heterologous immunoglobulin should be undertaken with the greatest caution and vigilance.
输注浓缩的异种血清蛋白可能会在人体中引发严重反应。其中一些反应并非由于对异体蛋白预先存在超敏反应,而是由于输注蛋白的强烈抗补体活性(ACA)。后一种机制可以解释在先前没有已知异体蛋白接触史的患者中偶尔出现的类过敏反应。同样,它也可以解释这样的患者,即对初步皮下试验剂量无反应,但随后在输注相同制剂时却出现虚脱。对来自九个国家的九种商业抗蛇毒血清进行了检测,发现大多数都具有高水平的抗补体活性。这些抗蛇毒血清在免疫化学性质和抗补体活性方面都存在相当大的差异。还发现马源性对白喉、破伤风和气性坏疽毒素的抗毒素也具有高抗补体活性。由于这种活性,这些制剂应始终稀释并缓慢输注。对试验剂量无反应并不能保证输注过程顺利,因此所有异种免疫球蛋白的输注都应极其谨慎并保持警惕。